-
公开(公告)号:US10414814B2
公开(公告)日:2019-09-17
申请号:US15322438
申请日:2015-07-02
发明人: John C. Williams , Ulrich Rodeck , Kurt Jenkins
IPC分类号: C07K14/82 , C07K16/46 , C07K14/705 , C12N9/64 , C07K14/435 , C07K19/00 , C07K16/28 , C07K14/47 , C07K14/71
摘要: Provided herein are recombinant masking proteins and recombinant ligand proteins useful in treating cancer, neurodegenerative disease, and cardiovascular disease. The recombinant masking proteins provided herein may, inter alia, be used as non-covalent masks of antagonists of, for example, cellular growth factors (e.g., TNF) or cell surface proteins (e.g., CTLA-4).
-
公开(公告)号:US11926652B2
公开(公告)日:2024-03-12
申请号:US15931077
申请日:2020-05-13
发明人: John Williams , Ulrich Rodeck , Miso Park , Kurt Jenkins
IPC分类号: C07K14/47 , A61K38/00 , A61K47/64 , A61K47/65 , C07K14/705
CPC分类号: C07K14/4703 , A61K47/64 , A61K47/65 , C07K14/70521 , A61K38/00 , C07K2319/055 , C07K2319/30 , C07K2319/50 , C07K2319/70 , C07K2319/74
摘要: Provided herein are recombinant CTLA-4 binding proteins, which are, inter alia, useful for the treatment of cancer. The recombinant proteins provided herein are, inter alia, capable of binding CTLA-4 proteins on a tumor cell. In a first aspect, there is provided a recombinant CTLA-4 binding protein including (i) a CTLA-4 binding domain; (ii) a CTLA-4 binding domain masking peptide; and (iii) a cleavable peptide linker connecting the CTLA-4 binding domain masking peptide to the CTLA-4 binding domain. In another aspect, there is provided a dimerizing domain covalently attached to the CTLA-4 binding domain, wherein the binding protein domains are bound together.
-
公开(公告)号:US11279752B2
公开(公告)日:2022-03-22
申请号:US16559561
申请日:2019-09-03
发明人: John C. Williams , Ulrich Rodeck , Kurt Jenkins
摘要: Provided herein are recombinant masking proteins and recombinant ligand proteins useful in treating cancer, neurodegenerative disease, and cardiovascular disease. The recombinant masking proteins provided herein may, inter alia, be used as non-covalent masks of antagonists of, for example, cellular growth factors (e.g., TNF) or cell surface proteins (e.g., CTLA-4).
-
-